Navigation Links
Roche confirms Tamiflu production talks in US

Swiss pharmaceutical giant Roche confirmed that it is in talks with 15 companies in the U.S. about stepping up the production of Tamiflu, the bird-flu drug//.

The partnership would dramatically increase the world's supply of Tamiflu as countries are stockpiling the drug in preparation for a possible bird flu pandemic.

The Basel-based firm confirmed on Thursday that it was in talks with Teva Pharmaceuticals and Mylan Laboratories, but declined to provide the names of any other companies.

"Roche is in advanced discussions with potential partners that can help enhance its supply chain and add capacity for certain specialized steps in the manufacturing of Tamiflu," the company said in a statement.

It added that it was "moving ahead as planned with third-party discussions" and would publish further details at a later date.

Increasing supply

The statement came after US Senator Charles Schumer said, "the purpose is not to break the patent on Tamiflu, but rather to meet an emergency need for quantities of this drug that Roche itself simply cannot do alone."

"Roche has made the right decision," Schumer said. "Instead of closely holding their patent rights and production techniques, in the face of a global health risk, they've moved swiftly to partner with multiple companies to dramatically increase production of this potentially life-saving drug."

The drug is in short supply in many parts of the world because of the fear of bird flu, a form of influenza that has been contracted by humans who have had close contact with infected poultry.

Tamiflu is one of four drugs known to work against influenza. It does not cure the virus but can reduce the severity of infection. Doctors believe it may help control a pandemic of H5N1 avian influenza, although evidence suggests it may be less effective than it is against seasonal influenza.

The drug, invented by California-based Gilead Sciences Inc., is in short supply. Countries are seeking to stockpile it but all are many million doses short of what would be needed to treat a pandemic of any sort of influenza, if there is one.

Last month Roche said Indonesia, Thailand and the Philippines were free to begin making their own versions of the drug because it does not have patent protection in these countries.

Related medicine news :

1. FDA Imposes New Restrictions On Roches Accutane
2. Roche offers HIV drug expertise to poor nations
3. Roche Commits More Antiviral Pills To Asia For Bird Flu
4. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
5. Roche Rolls Out Lung Cancer Drug In India
6. New Lung Cancer Drug Launched By Roche Pharmaceutical
7. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
8. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
9. NICE Gives the Final ‘NO’ to Roche’s Tarcva
10. SARS research confirms link to animals
11. Irritable bowel syndrome associated with food intake, confirms blood test
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... online platform for mental health and wellness consultation, has collaborated with a leading ... bridge the knowledge gap experienced by parents and bring advice from parenting experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Japanese Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: